AbbVie Partners With Valkai on AI Tools for Clinical Development
Sep 29, 2026
Biotech
AI4Eyes Joins MEDTEQ+ Avise Program with $700,000 Grant for Clinical Validation
Jul 7, 2026
Montreal-based AI4Eyes has been accepted into the MEDTEQ+ Avise Program and awarded $700,000 to validate its AI-powered dry eye diagnostic platform in real-world clinical settings.
Montreal-based AI4Eyes has been accepted into the MEDTEQ+ Avise Program and awarded $700,000 to support clinical validation of its artificial intelligence eye care platform, announced in a press release.
The funding will be used to test AI4Eyes’ dry eye diagnostic platform in real-world clinical environments. The one-year project will assess the system’s accuracy, integration into clinical workflows, ease of use, and efficiency in supporting patient care.
As part of the program, CIUSSS du Nord-de-l’Île-de-Montréal will serve as the official evaluator, overseeing the study and generating evidence on the platform’s clinical performance and usability.
AI4Eyes’ acceptance into the Avise Program follows a selection process supported by the Quebec Ministry of Economy, Innovation and Energy. The goal of the program is to help innovative health technologies reach the province’s healthcare system more quickly through evidence-based validation.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Oct 16 Matters Raises $5 Million to Build AI Consumer Bank Oct 16 KP Labs raises €4.42 million for AI data processing in orbit Oct 15 Origin Raises $20 Million for Autonomous Construction Robots Oct 15 Symbe Raises $5.7 Million for AI Sales Platform Oct 15 Cohere Agrees to Acquire AI Security Startup AISLEMore from Life Sciences
Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidenceFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
The Hackett Group
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
INmune Bio and QCi Apply Quantum Computing to XPro Research
Oct 14, 2026
Life Sciences
I-care Acquires Amiral Technologies for Predictive Maintenance AI
Sep 19, 2026
Acquisitions
Linearis Joins Two Canadian AI Health Data Projects
Sep 16, 2026
Healthcare
Elsevier Pledges 4,000 AI Tool Licenses for European Researchers
Oct 15, 2026
Scientific Research
CureMD Earns ISO/IEC 42001 Certification for AI Management
Oct 08, 2026
Healthcare
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.